Sales Associate, Cambrium

Salary not provided

+ Employee Stock Options

Junior and Mid level
Berlin
Paris
Cambrium

Engineering high-performance proteins

Job no longer available

Cambrium

Engineering high-performance proteins

21-100 employees

HealthcareB2BBiologyScience

Job no longer available

Salary not provided

+ Employee Stock Options

Junior and Mid level
Berlin
Paris

21-100 employees

HealthcareB2BBiologyScience

Company mission

To trigger the next wave of material innovation by harnessing biology's molecular building blocks.

Company mission

To trigger the next wave of material innovation by harnessing biology's molecular building blocks.

Our take

Animal-derived collagen has long been a staple in personal care, fashion, and other applications, but it comes with environmental and ethical concerns. Cambrium is stepping in with a sustainable alternative, leveraging cutting-edge technologies to design, scale, and manufacture novel molecular building blocks for man-made collagen.

Having secured funding and partnerships, Cambrium aims to transition the early successes of its skin-identical collagen ingredient NovaColl into a lasting impact, by scaling its manufacturing and commercial activities for animal-free collagen products.

Its technology not only presents a viable solution to reduce reliance on animal-derived collagen, but accelerates the development of other innovative biomolecules, suggesting a future where Cambrium could create high-performance, sustainable materials for various other sectors.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Funding (1 round)

Oct 2023

$9.5m

SEED

Total funding: $9.5m

Leadership

Mitchell Duffy

(Co-Founder & CEO)

Graduated from the University of Münster with a PhD in Molecular Imaging.

Charlie Cotton

(Co-Founder & CSO)

Graduated from the Imperial College London with a PhD in Structural and Synthetic Biology.